We propose that SLC2A1 may influence tumor growth and metastasis by modulating the G2M checkpoint and EMT while also regulating tumor metabolism through glycolysis and PI3K-AKT-mTOR signaling, enhancing tumor cell adaptability in hypoxic environments. The gene discussed is SLC2A1; the disease is neoplasm.